Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Regeneron Pharmaceuticals
(NQ:
REGN
)
666.16
+3.28 (+0.49%)
Streaming Delayed Price
Updated: 3:37 PM EDT, Jul 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Regeneron Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
63
64
Next >
Why Regeneron (REGN) Shares Are Trading Lower Today
May 18, 2026
What Happened? Shares of biotech company Regeneron (NASDAQ:REGN) fell 10.5% in the afternoon session after its experimental cancer treatment failed to meet t...
Via
StockStory
What's going on in today's session: S&P500 movers
↗
May 18, 2026
Via
Chartmill
Unusual volume S&P500 stocks in Monday's session
↗
May 18, 2026
Via
Chartmill
Discover which S&P500 stocks are making waves on Monday.
↗
May 18, 2026
Via
Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks
↗
May 18, 2026
Via
Chartmill
Regeneron Pharmaceuticals (NASDAQ:REGN) Beats Q1 Estimates, But Stock Slips on Margin Headwinds and Manufacturing Glitch
↗
April 29, 2026
Via
Chartmill
Which S&P500 stocks are moving before the opening bell on Monday?
↗
May 18, 2026
Via
Chartmill
Regeneron Announces Strategic Collaboration with Parabilis Medicines to Advance Novel Antibody-Helicon™ Conjugates Across Multiple Therapeutic Areas
May 18, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Regeneron Provides Update on Phase 3 Trial of Fianlimab (LAG-3 Inhibitor) Combination in First-Line Unresectable or Metastatic Melanoma
May 15, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Next Generation of Scientific Leaders Awarded More Than $7 Million at the 2026 Regeneron International Science and Engineering Fair
May 15, 2026
Hikaru Kuribayashi, 17, receives $100,000 Top Award for his creation of a simulation program to understand complex folding at the world’s largest pre-college STEM competition
From
Society For Science
Via
GlobeNewswire
3 Reasons to Sell REGN and 1 Stock to Buy Instead
May 14, 2026
Regeneron has been treading water for the past six months, recording a small return of 3.4% while holding steady at $717.22. The stock also fell short of the...
Via
StockStory
Will Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There.
↗
May 08, 2026
The competition is far behind.
Via
The Motley Fool
Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years
May 08, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Is This Biotech Stock a Buy After a Groundbreaking Approval?
↗
May 08, 2026
This milestone came with an asterisk.
Via
The Motley Fool
5 Must-Read Analyst Questions From Regeneron’s Q1 Earnings Call
May 06, 2026
Regeneron's first quarter performance delivered revenue and non-GAAP earnings per share above Wall Street expectations, as management cited strong commercial...
Via
StockStory
Topics
Earnings
Dupixent® (dupilumab) Demonstrates Improved Esophageal Function in Eosinophilic Esophagitis (EoE) Phase 4 Trial
May 05, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Is Regeneron a Buy After the FDA Approved its Gene Therapy to Restore Hearing?
↗
May 02, 2026
Regeneron is seeing double-digit revenue growth and has more than 50 therapies in its pipeline, making it a good long-term investment.
Via
The Motley Fool
1 Cash-Producing Stock Worth Investigating and 2 Facing Headwinds
May 01, 2026
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...
Via
StockStory
Regeneron Pharmaceuticals Analysts Cut Their Forecasts Following Q1 Earnings
↗
April 30, 2026
Regeneron Pharmaceuticals (NASDAQ: REGN) reported strong Q1 earnings and a $3B share buyback. Analysts have mixed views on the stock.
Via
Benzinga
REGN Q1 Deep Dive: Product Expansion Drives Growth, Margin Pressures Draw Scrutiny
April 30, 2026
Biotech company Regeneron (NASDAQ:REGN) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 19% year on year to $3.61 billion...
Via
StockStory
3 Healthcare Stocks We Keep Off Our Radar
April 30, 2026
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such a...
Via
StockStory
Why Regeneron (REGN) Shares Are Getting Obliterated Today
April 29, 2026
What Happened? Shares of biotech company Regeneron (NASDAQ:REGN) fell 7.1% in the afternoon session after its first-quarter 2026 earnings report revealed sig...
Via
StockStory
Topics
Artificial Intelligence
World Trade
Exploring the top movers within the S&P500 index during today's session.
↗
April 29, 2026
Via
Chartmill
These S&P500 stocks have an unusual volume in today's session
↗
April 29, 2026
Via
Chartmill
Regeneron (REGN) Q1 2026 Earnings Transcript
↗
April 29, 2026
Regeneron (REGN) Q1 2026 Earnings Transcript
Via
The Motley Fool
Which S&P500 stocks are moving on Wednesday?
↗
April 29, 2026
Via
Chartmill
Wednesday's session: gap up and gap down stock in the S&P500 index
↗
April 29, 2026
Via
Chartmill
Regeneron (NASDAQ:REGN) Reports Strong Q1 CY2026
April 29, 2026
Biotech company Regeneron (NASDAQ:REGN) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 19% year on year to $3.61 billion. I...
Via
StockStory
Regeneron Reports First Quarter 2026 Financial and Operating Results
April 29, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Regeneron (REGN) Q1 Earnings Report Preview: What To Look For
April 27, 2026
Biotech company Regeneron (NASDAQ:REGN) will be reporting earnings this Wednesday morning. Here’s what to expect. Regeneron beat analysts’ revenue expectatio...
Via
StockStory
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
63
64
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
